You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (5) |
Back to Search
Nevirapine-induced hepatotoxicity in hiv-infected individuals
- In: Hospital Pharmacy Section - Posters
- At: Beijing (China) (2007)
- Type: Poster
- Poster code: HPS-P-061
- By: MAZIDI, Talya (Tehran university of medical sciences, Tehran, Iran)
- Co-author(s): Khalili, hossein (Tehran university of medical sciences, TEHRAN, Iran)
- Abstract:
Aim: Nevirapine (NVP) has a main role in HAART regimen. It is useful for both post-exposure prophylaxis
and treatment of infected individuals, also it can reduce the risk of vertical transmission in infants born to infected mothers. Hepatotoxicity is one of the most serious adverse effects of NVP in which treatment discontinuation is.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026